Batch Alab: LoveYourself Blazes On In Its First Virtual Volunteer Batch Launch

After a decade of face-to-face orientation sessions, LoveYourself recently conducted its first virtual orientation for the newest batch …

An Open Letter to Trans Women, From Mela Habijan

This Women’s Month, and as we approach the International Transgender Day of Visibility, Mela inspires everyone once again with a message.

It’s Always Been “Yes”: Viñas Deluxe Joins the Fight on HIV Myths and Misconceptions

Drag performer extraordinaire Viñas Deluxe has grown comfortable under the spotlight and up the stage, being an entertainer …

Staying Educated is What’s “Peachy”: Peachy Roberts Out to Disprove HIV Misconceptions

LoveYourself’s very own Peachy Roberts enjoys her growing social media presence, with online shows and hosting stints filling …

Getting Facts “Inah” Your Mind: Inah Evans Helps Debunk HIV Myths

Inah shares her excitement on adding her personal flare to this important advocacy. The OG Baklang Kanal herself takes us “Inah” her mind in this LoveYourself interview.

Baklang Kanal Debunks HIV Myths and Misconceptions

Catch the Baklang Kanals as they loudly voice out the importance of sexual health, particularly HIV education, to the Philippine society. #SaferNowPH: Debunking HIV Myths and Misconceptions will run from mid-February until mid-April 2021.

Fit 2Gether in Celebrating International Condom Day 2021

Condoms remained to be in fashion amidst the COVID-19 pandemic. In celebrating the International Condom Day (ICD) 2021on …

LoveYourself Receives Duyan Ambassador Award

Project Red Ribbon’s Duyan Program recognizes its successful partnership with LoveYourself Inc. at last year’s Philippines International AIDS Candlelight Memorial (PIACM) Ceremony, awarding the organization with the Duyan Ambassador Award on February 3rd, 2021.

A New Drug of Choice for HIV Treatment in the Philippines

In a an online summit held on December 3, 2020 at The Club United in Parañaque City, streamed thru a video conferencing, Dr. Ditangco introduced the promising effects of Dolutegravir or DTG, the newly–identified ARV (anti–retroviral) drug in slowing down the replication of the Human Immunodeficiency Virus (HIV) inside the human body. DTG now stands to be the preferred treatment option across all populations.

LoveYourself in 2020: Staying Responsive, Upholding Advocacies

This year in a nutshell has been a challenging for all of us. However through the rollercoaster of …